Joel Greenblatt's NVO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 3,987 shares of Novo Nordisk A/S (NVO) worth $202,859, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in NVO, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3,987 | New Buy | 3,987 | $50.88 |
Joel Greenblatt's Novo Nordisk A/S Investment FAQs
Joel Greenblatt first purchased Novo Nordisk A/S (NVO) in Q4 2025, acquiring 3,987 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Novo Nordisk A/S (NVO) for 1 quarters since Q4 2025.
Joel Greenblatt's largest addition to Novo Nordisk A/S (NVO) was in Q4 2025, adding 3,987 shares worth $202,859.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 3,987 shares of Novo Nordisk A/S (NVO), valued at approximately $202,859.
As of the Q4 2025 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Novo Nordisk A/S (NVO) was 3,987 shares, as reported at the end of Q4 2025.